文献速递消化系统肿瘤

人胃癌干细胞来源伴侣分子-抗原肽疫苗的制备及其免疫功能

[Preparation of chaperone-antigen peptide vaccine derived from human gastric cancer stem cells and its immune function].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

该研究从人胃癌干细胞与胃癌细胞中提取伴侣分子-抗原肽复合物,经盐析、透析、亲和层析纯化后分析其组分与免疫活性。结果显示胃癌干细胞中复合物含量明显高于胃癌细胞,主要成分为HSP60、HSP70、HSP90和HSP110抗原肽;特定剂量HSP70-抗原肽和HSP90-抗原肽可激活淋巴细胞并增强杀伤活性。

要点

  • 成功制备并鉴定胃癌干细胞伴侣分子-抗原肽,主要组分为HSP60、HSP70、HSP90和HSP110抗原肽。
  • 0.75 μg和1.00 μg HSP70-抗原肽及1.00 μg HSP90-抗原肽对淋巴细胞有明显增殖作用。
  • 1.00 μg HSP70-抗原肽和1.00 μg HSP90-抗原肽的细胞杀伤率分别高于对应HSP70和HSP90组。

核心结论

  • 胃癌细胞中伴侣分子-抗原肽含量极低,而胃癌干细胞中含量明显增多,经提纯可制备纯度较高的伴侣分子-抗原肽。
  • 提取的伴侣分子-抗原肽具有较强的免疫原性,可在体外制作瘤苗,可能在胃癌靶向治疗上有较好的应用价值。

研究设计与样本

  • 研究采用低温超声裂解筛选胃癌干细胞和胃癌细胞,经盐析粗提蛋白及透析后,用SDS-PAGE分析伴侣分子-抗原肽表达量。
  • 采用溴化氰活化琼脂糖凝胶4B亲和层析分离纯化,用反向高压液相色谱、SDS-PAGE和Western blot法分析蛋白纯度。
  • 采用淋巴细胞增殖实验和细胞毒活性实验检测伴侣分子-抗原肽的免疫活性。

主要发现

  • 成功制备并鉴定胃癌干细胞的伴侣分子-抗原肽,主要组分为HSP60-抗原肽、HSP70-抗原肽、HSP90-抗原肽和HSP110-抗原肽。
  • 0.75 μg HSP70-抗原肽、1.00 μg HSP70-抗原肽和1.00 μg HSP90-抗原肽对淋巴细胞有明显增殖作用,A(490)值分别为0.26±0.03、0.45±0.05和0.32±0.04;相应剂量的HSP60-抗原肽和HSP110-抗原肽不能激活淋巴细胞。
  • 1.00 μg HSP70-抗原肽组和1.00 μg HSP70组的细胞杀伤率分别为(45.0±2.0)%和(16.0±2.0)%,差异有统计学意义(P=0.012)。
  • 1.00 μg HSP90-抗原肽组和1.00 μg HSP90组的细胞杀伤率分别为(36.0±5.0)%和(13.0±4.0)%,差异有统计学意义(P=0.048)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the method of extracting chaperone antigen peptide complexes from gastric cancer stem cells and its immune function. Methods: Gastric cancer stem cells and gastric cancer cells were screened by low temperature ultrasonic lysis. After salting out and dialysis, the lysate supernatant was processed with SDS-PAGE to analyze the expression of chaperone antigen peptide complexes, and then was separated and purified with CNBr-activated SepharoseTM 4B. Reverse high pressure liquid chromatography (HPLC), SDS-PAGE and Western blotting were used to analyze the purity and nature of the acquired albumen. Lymphocyte proliferation assay and lymphocytotoxicity assay were used to ditermine the immunological activity of the chaperone-antigen peptide complexes. Results: The chaperone antigen peptide complexes of gastric cancer stem cells were prepared and identified successfully, of which the main components were the antigen peptides of HSP60, HSP70, HSP90 and HSP110. 0.75 μg and 1.00 μg HSP70-antigen peptide and 1.00 μg HSP90-antigen peptide activated lymphocytes significantly. Their A(490) values were 0.26±0.03, 0.45±0.05 and 0.32±0.04, respectively, while the corresponding doses of HSP60-antigen peptide and HSP110-antigen peptide did not activate lymphocytes. The killing rates of 1.00 μg HSP70-antigen peptide and 1.00 μg HSP70 were (45.0±2.0)% and (16.0±2.0)%, respectively, showing a significant difference (P=0.012). Similarly, the killing rates of 1.00 μg HSP90-antigen peptide and 1.00 μg HSP90 were (36.0±5.0)% and (13.0±4.0)%, respectively, also showing a significant difference (P=0.048). Conclusions: The amount of chaperone antigen peptide complexes in gastric cancer cells is extremely low, but it is obviously increased in gastric cancer stem cells. After purification, the chaperone antigen peptide complexes with high purity can be prepared. The extracted chaperone antigen peptide complexes have stronger immunogenicity, and can be used to make tumor vaccine in vitro, which may have a good application value in the targeted therapy of gastric cancer. 目的: 探讨从胃癌干细胞中提取伴侣分子-抗原肽的方法及其免疫功能。 方法: 低温超声裂解筛选胃癌干细胞和胃癌细胞,经盐析粗提蛋白及透析后,采用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)分析伴侣分子-抗原肽表达量,采用溴化氰活化琼脂糖凝胶4B亲和层析分离、纯化伴侣分子-抗原肽,采用反向高压液相色谱、SDS-PAGE和Western blot法进行蛋白纯度分析,采用淋巴细胞增殖实验和细胞毒活性实验检测伴侣分子-抗原肽的免疫活性。 结果: 成功制备并鉴定胃癌干细胞的伴侣分子-抗原肽,主要组分为HSP60-抗原肽、HSP70-抗原肽、HSP90-抗原肽和HSP110-抗原肽。0.75 μg HSP70-抗原肽、1.00 μg HSP70-抗原肽和1.00 μg HSP90-抗原肽对淋巴细胞有明显的增殖作用,其A(490)值分别为0.26±0.03、0.45±0.05和0.32±0.04,而相应剂量的HSP60-抗原肽和HSP110-抗原肽不能激活淋巴细胞。1.00 μg HSP70-抗原肽组和1.00 μg HSP70组的细胞杀伤率分别为(45.0±2.0)%和(16.0±2.0)%, 差异有统计学意义(P=0.012)。1.00 μg HSP90-抗原肽组和1.00 μg HSP90组的细胞杀伤率分别为(36.0±5.0)%和(13.0±4.0)%,差异有统计学意义(P=0.048)。 结论: 胃癌细胞中伴侣分子-抗原肽含量极低,而胃癌干细胞中伴侣分子-抗原肽含量明显增多,经提纯后可制备纯度较高的伴侣分子-抗原肽。提取的伴侣分子-抗原肽具有较强的免疫原性,可在体外制作瘤苗,可能在胃癌靶向治疗上有较好的应用价值。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jiang YQ, Guo QM, Xu XP, et al. [Preparation of chaperone-antigen peptide vaccine derived from human gastric cancer stem cells and its immune function]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28219205. doi:10.3760/cma.j.issn.0253-3766.2017.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。